03 Apr 2021
UK: Seven blood-clotting-related deaths in 18mn AstraZeneca COVID-19 vaccine recipients
On Saturday, the United Kingdom's medical regulator said that seven people—out of more than 18 million recipients of the Oxford-AstraZeneca jab for COVID-19 in the country—died of unusual blood clots.
20 Feb 2021
Three month gap between Oxford vaccine jabs provides better efficacy
A three-month interval between doses of the Oxford COVID-19 vaccine results in higher vaccine efficacy compared to a six-week gap, according to a new study which says the first dose can offer up to 76 percent protection in the months between the two jabs.
19 Feb 2021
Sri Lanka to purchase ten million Covishield doses from India
Sri Lanka will purchase ten million doses of Oxford-AstraZeneca's Covishield vaccine from India, officials have said.
29 Jan 2021
Johnson & Johnson's one-shot COVID-19 vaccine shows 66% strong efficacy
Johnson & Johnson's (J&J) much-awaited COVID-19 vaccine has reportedly exhibited strong protection against the virus.
26 Jan 2021
Diplomats, including from Pakistan and China, offered coronavirus vaccines
After starting its vaccination drive on January 16, New Delhi has offered made-in-India vaccines to diplomatic corps, including to those from Pakistan and China.
21 Jan 2021
Pune: Fire breaks out at Serum Institute of India
On Thursday afternoon, a fire broke out at the Terminal 1 gate of Serum Institute of India, Pune.
21 Jan 2021
Coronavirus: PM Modi, CMs to get vaccinated in second phase
Prime Minister Narendra Modi, 70, would be getting the coronavirus vaccine shot in the second phase of the drive launched last week, reports said on Thursday.
01 Jan 2021
India set to start COVID-19 vaccination; panel approves Oxford vaccine
In a development that will soothe the coronavirus-battered nation, the Central Drugs Standard Control Organization (CDSCO) panel on Friday gave approval to the vaccine developed by the University of Oxford and British-pharma giant AstraZeneca.
31 Dec 2020
UK's approval to Oxford-AstraZeneca vaccine paves way for India
The United Kingdom on Wednesday approved the vaccine developed by Oxford University and the British-Swedish pharmaceutical company AstraZeneca, giving the vaccine an endorsement that will likely be considered by Indian drug regulators.
23 Dec 2020
Awaiting COVID-19 vaccine arrival, Delhi hospital working on storage facility
From installing freezers to cold chain equipment set up, arrangements are being made at a Delhi government hospital for storage of the COVID-19 vaccine, anticipating its arrival, sources said on Tuesday.
23 Dec 2020
Indian government could approve Oxford-AstraZeneca's coronavirus vaccine by next week
The coronavirus vaccine, developed by the University of Oxford and AstraZeneca, is likely to get approval from the Indian government for emergency use by next week, two people privy to the development told Reuters.
21 Dec 2020
Coronavirus vaccination may start in January, says Health Minister
India may begin vaccinating people against coronavirus in January, Union Health Minister Dr. Harsh Vardhan said on Sunday, giving hope to a country that has lost more than a lakh to the fatal disease.
13 Dec 2020
How Delhi plans to carry out COVID-19 vaccinations
Ahead of the licensing of a COVID-19 vaccine, the Delhi government has been working on a plan to conduct vaccinations.
12 Dec 2020
Kerala becomes fourth state to promise free COVID-19 vaccines
Kerala Chief Minister Pinarayi Vijayan on Saturday said that COVID-19 vaccines will be provided for free in the state.
12 Dec 2020
Here's how the government is planning to conduct COVID-19 vaccinations
With licensing for COVID-19 vaccines expected in the coming weeks, the government has drafted a plan for vaccination campaigns.
09 Dec 2020
Oxford-AstraZeneca release final-stage trial results, coronavirus vaccine labeled safe
The University of Oxford and pharmaceutical firm AstraZeneca became the first coronavirus vaccine developers to release their final-stage clinical trial data.
27 Nov 2020
India to produce 100 million Sputnik V doses starting 2021
India will produce over 100 million doses a year of the Russian COVID-19 vaccine Sputnik V starting 2021, under an agreement between the Russian Direct Investment Fund (RDIF) and Hyderabad-based Hetero Biopharma, Hindustan Times reported.
26 Nov 2020
Manufacturing error in Oxford-AstraZeneca coronavirus vaccine raises pertinent questions
After announcing that their coronavirus vaccine candidate was nearly 70% effective, the University of Oxford and its partner, AstraZeneca, on Wednesday admitted to a manufacturing error, which has now sparked important questions about the results.
18 Nov 2020
India relying on five coronavirus vaccines to control pandemic
With heartening news of the coronavirus vaccine coming from different parts of the world, the Indian government is trying to understand which one would be the most feasible for the country.
08 Nov 2020
Vaccine tracker: Covishield trials running smoothly; COVAXIN expected by February
Even as the COVID-19 outbreak has witnessed a downward trend in India, some states have been reporting large spikes in infections, indicating that the pandemic is far from over.
01 Nov 2020
Vaccine tracker: Covishield expected by December; Moderna readies for launch
It has been almost a year since the coronavirus pandemic began, yet the virus is far from being brought under control.
22 Oct 2020
Coronavirus: India reserves Rs. 50,000 crore for vaccinating entire country
The Indian government has reportedly set aside Rs. 50,000 crore to ensure that the COVID-19 vaccine reaches the entire country.
01 Oct 2020
NewsBytes Briefing: Google launches new Pixel phones, and more
Last night, Google held its Launch night event and showcased a bunch of new devices, including 5G-capable Pixel 5 and Pixel 4a, a new Chromecast dongle with mic-integrated remote, and redesigned, more powerful Nest Audio speakers.
27 Aug 2020
Coronavirus vaccine tracker: When will one be ready?
The global effort to develop a vaccine against the novel coronavirus SARS-CoV-2 continues as over 24 million people have been infected worldwide.
30 Jul 2020
Coronavirus: How much would the vaccines cost?
As the coronavirus pandemic continues to surge, all hopes rest on the development of a vaccine to beat the virus.